Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment.

Cardiologists applaud FDA’s approval of colchicine for CVD

"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug. 

physician money payments dollars

Physician-owned hospitals charge less for imaging than their counterparts

The finding comes as lobbying groups urge Congress to repeal an ongoing moratorium on doc hospital ownership

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

Moderna's updated COVID vaccine now awaits FDA authorization

"We have been working diligently for months to build ample supply, with doses ready to ship in time for the fall vaccination season in the Northern Hemisphere,” Moderna's CEO said in the announcement.

female physician male

American College of Radiology, AMA partner to fight nonphysician scope creep

ACR recently highlighted the collaboration, labeling scope of practice as “one of the leading issues that are addressed by state legislatures.” 

artificial intelligence robot evaluates healthcare data

FDA grants breakthrough designation for new AI model to detect cardiac amyloidosis in ECG results

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.

Thumbnail

Bristol Myers Squibb joins others suing US government over portions of the Inflation Reduction Act

The Drug Price Negotiation Program already has changed how the company considers the development of future oncology programs and medications. 

Thumbnail

USPSTF now recommends screening all adults for anxiety disorders

This is the first time that the task force has recommended screening for anxiety disorders in an asymptomatic adult population.

Thumbnail

Surprise-billing legislation took away Envision Healthcare’s ‘secret sauce,’ health economist says

Eileen Appelbaum, PhD, spoke during the Take Back Medicine summit, focused on the theme of “reclaiming medicine from corporate interests.” 

Displaying 1113 - 1120 of 3622
Design by Adaptive Theme